Certified by Founder Lodge
Catalys Pacific
Japan - Minato-ku, Tokyo
INVESTOR
1 Disclosed Funding Rounds $150,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys Pacific has assembled a group of Strategic and Preferred Partners with whom to create as
| Company | Date | Round | Raised |
|---|---|---|---|
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Pathalys Pharma |
February, 07 ,2023 | Unknown | $150,000,000 |
Arialys Therapeutics, Inc. |
September, 13 ,2023 | Seed | $58,000,000 |
Crystalys Therapeutics |
October, 01 ,2025 | Series A | $205,000,000 |
Crystalys Therapeutics
Pathalys Pharma
Arialys Therapeutics, Inc.
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)